drugset / Trial / NCT02212275
Cortical Metrics in Intervention Trials With Autism Spectrum Disorders
Phase 2/3
Withdrawn
Duke University
North Carolina Translational and Clinical Sciences Institute · collab
Non-randomizedSingle-groupOpen-label
Summary
The investigators overarching aim is to obtain preliminary data to support a larger grant to validate a novel objective, physiologically-based outcome measure for clinical trials in autism spectrum disorders (ASDs) called the cortical metric. Absence of such an outcome measure has greatly hindered the development of treatments for core symptoms of ASD.
Timeline
- Start
- 2015-08
- Primary completion
- 2016-07
- Completion
- 2016-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dextromethorphan | Unknown | — | — |